or Try an Advanced Search...

    Technical Analysis for SPRO - Spero Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 1.47 -3.92% -0.06
    SPRO closed down 3.92 percent on Tuesday, April 16, 2024, on 47 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical SPRO trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 50 DMA Bearish -3.92%
    MACD Bearish Centerline Cross Bearish -3.92%
    New Downtrend Bearish -3.92%
    Expansion Pivot Sell Setup Bearish Swing Setup -3.92%
    Older End-of-Day Signals for SPRO ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 3 hours ago
    Down 3% about 3 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    Reversed from Up about 5 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SPRO Chart by TradingView
    Basic chart:

    Profile

    Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Bacterial Infections Veterinary Medicine Regulus Therapeutics Antimicrobial Resistance Drug Resistant Bacterial Infections Evolutionary Biology Multi Drug Resistant Bacterial Infections

    Is SPRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 17 Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
    Mar 15 Spero Therapeutics files $300M mixed securities shelf
    Mar 15 Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript
    Mar 15 Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
    Mar 14 Q4 2023 Spero Therapeutics Inc Earnings Call
    Mar 13 Spero Therapeutics, Inc. (SPRO) Q4 2023 Earnings Call Transcript
    Mar 13 Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates
    Mar 13 Spero Therapeutics GAAP EPS of $0.96 beats by $1.06, revenue of $73.5M beats by $54.87M
    Mar 13 Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
    Mar 13 Earnings Scheduled For March 13, 2024
    See more SPRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.99
    52 Week Low 0.99
    Average Volume 344,022
    200-Day Moving Average 1.40
    50-Day Moving Average 1.63
    20-Day Moving Average 1.70
    10-Day Moving Average 1.66
    Average True Range 0.09
    RSI (14) 32.89
    ADX 33.41
    +DI 9.42
    -DI 20.35
    Chandelier Exit (Long, 3 ATRs) 1.56
    Chandelier Exit (Short, 3 ATRs) 1.75
    Upper Bollinger Bands 1.87
    Lower Bollinger Band 1.54
    Percent B (%b) -0.22
    BandWidth 19.09
    MACD Line -0.02
    MACD Signal Line 0.01
    MACD Histogram -0.0323
    Fundamentals Value
    Market Cap 77.91 Million
    Num Shares 53 Million
    EPS 0.39
    Price-to-Earnings (P/E) Ratio 3.77
    Price-to-Sales 1.02
    Price-to-Book 1.35
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.68
    Resistance 3 (R3) 1.70 1.66 1.65
    Resistance 2 (R2) 1.66 1.60 1.65 1.63
    Resistance 1 (R1) 1.56 1.57 1.54 1.54 1.62
    Pivot Point 1.52 1.52 1.51 1.51 1.52
    Support 1 (S1) 1.42 1.46 1.40 1.40 1.32
    Support 2 (S2) 1.38 1.43 1.37 1.31
    Support 3 (S3) 1.28 1.38 1.30
    Support 4 (S4) 1.26